Development and evaluation of novel phosphotyrosine mimetic inhibitors targeting the Src homology 2 domain of signaling lymphocytic activation molecule (SLAM) associated protein

Journal of Medicinal Chemistry

Volumn 56, Issue 7, 2013, Pages 2841-2849

  Chu, Chi Yuan ^a   Chang, Chun Ping ^b,c   Chou, Yun Ting ^a   Handoko, ^a   Hu, Yi Ling ^a   Lo, Lee Chiang ^a   Lin, Jing Jer ^b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; PHOSPHOTYROSINE; PHOSPHOTYROSINE DERIVATIVE; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; IC 50; MOLECULAR DOCKING; NONHUMAN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN;

BINDING SITES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, MOLECULAR; MOLECULAR MIMICRY; PHOSPHOTYROSINE; SRC HOMOLOGY DOMAINS;

EID: 84876237519     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm301610q     Document Type: Article

References (24)

1. Filippakopoulos, P.; Muller, S.; Knapp, S. SH2 domains: modulators of nonreceptor tyrosine kinase activity Curr. Opin. Struct. Biol. 2009, 19, 643-649
2. Liu, B. A.; Jablonowski, K.; Raina, M.; Arce, M.; Pawson, T.; Nash, P. D. The human and mouse complement of SH2 domain proteins: Establishing the boundaries of phosphotyrosine signaling Mol. Cell 2006, 22, 851-868
3. Cannons, J. L.; Tangye, S. G.; Schwartzberg, P. L. SLAM family receptors and SAP adaptors in immunity Annu. Rev. Immunol. 2011, 29, 665-705
4. Schwartzberg, P. L.; Mueller, K. L.; Qi, H.; Cannons, J. L. SLAM receptors and SAP influence lymphocyte interactions, development and function Nat. Rev. Immunol. 2009, 9, 39-46
5. Machida, K.; Mayer, B. J. The SH2 domain: versatile signaling module and pharmaceutical target Biochim. Biophys. Acta 2005, 1747, 1-25
6. Siddiquee, K.; Zhang, S.; Guida, W. C.; Blaskovich, M. A.; Greedy, B.; Lawrence, H. R.; Yip, M. L. R.; Jove, R.; McLaughlin, M. M.; Lawrence, N. J.; Sebti, S. M.; Turkson, J. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 7391-7396
7. Dekker, F. J.; de Mol, N. J.; Fischer, M. J. E.; Kemmink, J.; Liskamp, R. M. J. Cyclic phosphopeptides for interference with Grb2 SH2 domain signal transduction prepared by ring-closing metathesis and phosphorylation Org. Biomol. Chem. 2003, 1, 3297-3303
8. Song, Y.-L.; Tan, J.; Luo, X.-M.; Long, Y.-Q. Utilization of 3-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain Org. Biomol. Chem. 2006, 4, 659-666
9. Song, Y.-L.; Peach, M. L.; Roller, P. P.; Qiu, S.; Wang, S.; Long, Y.-Q. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3′-substituted tyrosine derivatives J. Med. Chem. 2006, 49, 1585-1596
10. Zhang, Y.; Zhou, S.; Wavreille, A.-S.; DeWille, J.; Pei, D. Cyclic peptidyl inhibitors of Grb2 and tensin SH2 domains identified from combinatorial libraries J. Comb. Chem. 2008, 10, 247-255
11. Quartararo, J. S.; Wu, P.; Kritzer, J. A. Peptide bicycles that inhibit the Grb2 SH2 domain ChemBioChem 2012, 13, 1490-1496
12. Huang, Y.-Y.; Kuo, C.-C.; Chu, C.-Y.; Huang, Y.-H.; Hu, Y.-L.; Lin, J.-J.; Lo, L.-C. Development of activity-based probes with tunable specificity for protein tyrosine phosphatase subfamilies Tetrahedron 2010, 66, 4521-4529
13. Pozdnev, V. F. Application of di- tert -butyl pyrocarbonate as condensing reagent in the synthesis of amides of protected amino acids and peptides Tetrahedron Lett. 1995, 36, 7115-7118
14. Sayos, J.; Wu, C.; Morra, M.; Wang, N.; Zhang, X.; Allen, D.; van Schail, S.; Notarangelo, L.; Geha, R.; Roncarolo, M. G.; Oettgen, H.; De Vries, J. E.; Aversa, G.; Terhorst, C. The X-linked lymphoproliferativedisease gene product SAP regulates signals induced through the co-receptor SLAM Nature 1998, 395, 462-469
15. Coffey, A. J.; Brooksbank, R. A.; Brandau, O.; Oohashi, T.; Howell, G. R.; Bye, J. M.; Cahn, A. P.; Durham, J.; Heath, P.; Wray, P.; Pavitt, R.; Wilkinson, J.; Leversha, M.; Huckle, E.; Shaw-Smith, C. J.; Dunham, A.; Rhodes, S.; Schuster, V.; Porta, G.; Yin, L.; Serafini, P.; Sylla, B.; Zollo, M.; Franco, B.; Bolino, A.; Seri, M.; Lanyi, A.; Davis, J. R.; Webster, D.; Harris, A.; Lenoir, G.; de St Basile, G.; Jones, A.; Behloradsky, B. H.; Achatz, H.; Murken, J.; Fassler, R.; Sumegi, J.; Romeo, G.; Vaudin, M.; Ross, M. T.; Meindl, A.; Bentley, D. R. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene Nat. Genet. 1998, 20, 129-135
16. Nichols, K. E.; Harkin, D. P.; Levitz, S.; Krainer, M.; Koloquist, K. A.; Genovese, C.; Bernard, A.; Ferguson, M.; Zuo, L.; Synder, E.; Buckler, A. J.; Wise, C.; Ashley, J.; Lovett, M.; Valentine, M. B.; Look, A. T.; Gerald, W.; Housman, D. E.; Haber, D. A. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 13765-13770
17. Poy, F.; Yaffe, M. B.; Sayos, J.; Saxena, K.; Morra, M.; Sumegi, J.; Cantley, L. C.; Terhorst, C.; Eck, M. J. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition Mol. Cell 1999, 4, 555-561
18. Li, S. C.; Gish, G.; Yang, D.; Coffey, A. J.; Forman-Kay, J. D.; Ernberg, I.; Kay, L. E.; Pawson, T. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A Curr. Biol. 1999, 9, 1355-1362
19. Hwang, P. M.; Li, C.; Morra, M.; Lillywhite, J.; Muhandiram, D. R.; Gertler, F.; Terhorst, C.; Kay, L. E.; Pawson, T.; Forman-Kay, J. D.; Li, S.-C. A 'three-pronged' binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome EMBO J. 2002, 21, 314-323
20. Finerty, P. J., Jr.; Muhandiram, R.; Forman-Kay, J. D. Side-chain dynamics of the SAP SH2 domain correlate with a binding hot spot and a region with conformational plasticity J. Mol. Biol. 2002, 322, 605-620
21. Rutenber, E. E.; De Voss, J. J.; Hoffman, L.; Stroud, R. M.; Lee, K. H.; Alvarez, J.; McPhee, F.; Craik, C.; Ortiz de Montellano, P. R. The discovery, characterization and crystallographically determined binding mode of an Fmoc-containing inhibitor of HIV-1 protease Bioorg. Med. Chem. 1997, 5, 1311-1320
22. Trott, O.; Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading J. Comput. Chem. 2010, 31, 455-461
23. Baker, N. A.; Sept, D.; Joseph, S.; Holst, M. J.; McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 10037-10041
24. Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual molecular dynamics J. Mol. Graphics 1996, 14, 33-38